The Patent Finder

Terms ending in 2031

Genmab A/S

Every in-force patent on Genmab A/S's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,657,107Monoclonal Antibodies Against C-Met
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,085,625Antibody Variants Having Modifications In The Constant Region
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 8,802,089Monoclonal Antibodies Against CD32B
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 8,529,902Human Monoclonal Antibodies Against CD20
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,150,663Heterodimeric Antibody Fc-Containing Proteins and Methods for Production Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,597,464Heterodimeric Antibody Fc-Containing Proteins and Methods for Production Thereof
In force
 · Low confidence
Genmab A/SIn forceLow confidence
US 9,944,711Antibodies Against Human CD38
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,068,011Monoclonal Antibodies Against C-Met
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 9,168,314Human Antibody Drug Conjugates Against Tissue Factor
In force
 · Medium confidence
Genmab A/SIn forceMedium confidence
US 9,249,226Antibodies Against Human CD38
In force
 · High confidence
Genmab A/SIn forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited